KingMed Diagnostics Share Price Down 7% on Accusation of Employee's Covid-19 Violation

Garrett_Li

Garrett_...

· 1月13日

Zhang is suspected of violating rules of pandemic control and prevention and causing the spread of the coronavirus, according to the announcement. It is unclear how Zhang had violated the rules due to the lack of details in the announcement. The case is still under investigation.

BEIJING, January 12 (TMTPOST) — A regional manager of Zhengzhou KingMed, surnamed Zhang, has been detained by the authorities on suspicion of causing the spread of Covid-19, the Public Security Bureau of Xuchang city announced.

Zhang is suspected of violating rules of pandemic control and prevention and causing the spread of the coronavirus, according to the announcement. It is unclear how Zhang had violated the rules due to the lack of details in the announcement. The case is still under investigation.

There are numerous speculations about the incident, including voluntary and active spread of covid, falsifying data and hiding covid cases, which the company has claimed to be purely fake news and rumors in an announcement on its Weibo page. There are rumors on the Internet that claim KingMed Diagnostics’ staff lost some of the covid test samples and falsified negative results.

The share price of Guangzhou KingMed Diagnostics Group Co. Ltd., which is the parent company of Zhengzhou KingMed, fell by as much as over 7% during trading on Wednesday. KingMed’s share price closed as 91 yuan per share, registering a 5.79%. KingMed’s market valuation had fallen by over two billion yuan to 42.37 billion yuan as a result.

KingMed Diagnostics had pledged to cooperate with the authorities to investigate the matter and would make timely disclosure of investigation results to the public.

“The company is working with the authorities on the investigation. Zhengzhou KingMed’s medical diagnostic services are not affected by this incident,” the company’s spokesperson said.

Zhengzhou KingMed is reportedly responsible of one-third of the covid tests in Zhengzhou, one of the biggest cities in central China with a population of 10.35 million. The company has made revenue of 3.36 billion yuan in Q1-Q3 2021 from its covid testing business. Zhengzhou KingMed had performed 10 million covid tests as of October 2021.

Founded in 2006, Guangzhou KingMed Diagnostics Group specializes in medical testing. It is one of the largest third-party medical testing service providers in China with 38 labs in China. The company has labs in Guangzhou, Beijing, Shanghai and Nanjing and Hong Kong, etc. Its services cover areas accommodating 90% of the country's population.

本文系作者Garrett_Li授权钛媒体发表,并经钛媒体编辑,转载请注明出处、作者和本文链接
本文观点仅代表作者本人,钛媒体平台仅对用户提供信息及决策参考,本文不构成投资建议。
想和千万钛媒体用户分享你的新奇观点和发现,点击这里投稿 。创业或融资寻求报道,点击这里

敬原创,有钛度,得赞赏

”支持原创,赞赏一下“
钛粉30326 钛ae5u70 满级钛宝16422180875 马洋928 钛小超16395556011 钛粉25713
514人已赞赏 >
514换成打赏总人数514人赞赏钛媒体文章
关闭弹窗

挺钛度,加点码!

  • ¥ 5
  • ¥ 10
  • ¥ 20
  • ¥ 50
  • ¥ 100

支付方式

确认支付
关闭弹窗

支付

支付金额:¥6

关闭弹窗
sussess

赞赏金额:¥ 6

赞赏时间:2020.02.11 17:32

关闭弹窗 关闭弹窗

注册邮箱未验证

我们已向下方邮箱发送了验证邮件,请查收并按提示验证您的邮箱。

如果您没有收到邮件,请留意垃圾邮件箱。

更换邮箱

您当前使用的邮箱可能无法接收验证邮件,建议您更换邮箱

账号合并

经检测,你是“钛媒体”和“商业价值”的注册用户。现在,我们对两个产品因进行整合,需要您选择一个账号用来登录。无论您选择哪个账号,两个账号的原有信息都会合并在一起。对于给您造成的不便,我们深感歉意。